CIK 0001829802 · <br>Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-10 | Vojta Deneen Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | English Jessie Director | Grant or award | +4,466 | 4,466 | ||
| 2022-06-10 | English Jessie Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | RICKS THOMAS G Director | Grant or award | +4,466 | 4,466 | ||
| 2022-06-10 | RICKS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | Humer Kristian Director | Grant or award | +4,466 | 4,466 | ||
| 2022-06-10 | Humer Kristian Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | Broder Samuel Director | Grant or award | +4,466 | 4,466 | ||
| 2022-06-10 | Broder Samuel Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | Holmen Bob Director | Grant or award | +4,466 | 21,132 | ||
| 2022-06-10 | Holmen Bob Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-01 | Gallagher Patrick Stephen Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-03-02 | Peyer James Director | Purchase | +1,203 | $3.20 | $4K | 5,231,488 |
| 2022-03-02 | Cambrian BioPharma Inc 10% owner | Purchase | +1,203 | $3.20 | $4K | 5,231,488 |
| 2021-03-23 | Peyer James Director | Purchase | +9,500 | $14.34 | $136K | 4,798,293 |
| 2021-03-23 | Cambrian BioPharma Inc 10% owner | Purchase | +9,500 | $14.34 | $136K | 4,798,293 |
| 2021-02-18 | Peyer James Director | Purchase | +752 | $19.75 | $15K | 4,690,905 |
| 2021-02-18 | Cambrian BioPharma Inc 10% owner | Purchase | +752 | $19.75 | $15K | 4,690,905 |
Page 12 of 12 · 238 trades